BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25536642)

  • 1. Factors associated with recurrence and survival in liver transplant patients with HCC--a single center retrospective study.
    Hoyos S; Escobar J; Cardona D; Guzmán C; Mena Á; Osorio G; Pérez C; Restrepo JC; Correa G
    Ann Hepatol; 2015; 14(1):58-63. PubMed ID: 25536642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
    Mourad MM; Algarni A; Aly MA; Gunson BK; Mergental H; Isaac J; Muiesan P; Mirza D; Perera MT; Bramhall SR
    Exp Clin Transplant; 2015 Aug; 13(4):333-8. PubMed ID: 26295183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.
    Kim PT; Jang JH; Atenafu EG; Fischer S; Greig PD; McGilvray ID; Wei AC; Gallinger S; Cleary SP
    Br J Surg; 2013 Oct; 100(11):1516-22. PubMed ID: 24037575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
    Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in patients with hepatocellular carcinoma: a single-center experience.
    Azzam AZ; Hegab B; Khalaf H; Al Bahili H; Mohammed H; Kamel Y; Abaalkhail F; Al-hamoudi W; Al Sofayan M; Al Sebayel M
    Exp Clin Transplant; 2011 Oct; 9(5):323-8. PubMed ID: 21967259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
    Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
    Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
    Romani F; Belli LS; Rondinara GF; DeCarlis L; Rimoldi P; Riolo F; Bellati G; Ideo G; Belli L
    J Am Coll Surg; 1994 Apr; 178(4):379-84. PubMed ID: 8149037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus.
    Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
    Surgery; 2015 Feb; 157(2):239-48. PubMed ID: 25616940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
    Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.